SEC Form D filing
Haku Bio, Inc., 2026-03-02
An SEC Form D private-offering notice from Arlington, MA, an undisclosed offering target in Biotech. Filed 2026-03-02. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Haku Bio, Inc. Verified via SEC Form D
Filed 2026-03-02Filed to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2026-02-09Raised so far $210,000HQ (as filed) Arlington, MASector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Debt-only offering
Source linked the Form D on EDGAR↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- MacroCycle Technologies Inc., 2026-03-03, $3M, Cambridge, MA
- Allyx Therapeutics, Inc., 2026-03-03, $4M, New Haven, CT
- Boston Electrometallurgical Corp, 2026-03-03, $100M, Woburn, MA
- Ember LifeSciences, Inc., 2026-03-03, $50M, Westlake Village, CA
- Aegle Therapeutics Corp, 2026-03-03, $700K, Woburn, MA
- Marvix AI, Inc., 2026-02-27, $2.8M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.